S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase

S100A4 expression is associated with poor clinical outcomes of patients with pancreatic cancer. The effects of loss or gain of S100A4 were examined in pancreatic cancer cell lines. S100A4 downregulation remarkably reduces cell migration and invasion, inhibits proliferation and induces apoptosis in p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scientific reports 2015-02, Vol.5 (1), p.8453-8453, Article 8453
Hauptverfasser: Che, Pulin, Yang, Youfeng, Han, Xiaosi, Hu, Meng, Sellers, Jeffery C., Londono-Joshi, Angelina I., Cai, Guo-Qiang, Buchsbaum, Donald J., Christein, John D., Tang, Qinjiu, Chen, Dongquan, Li, Qianjun, Grizzle, William E., Lu, Yin Ying, Ding, Qiang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 8453
container_issue 1
container_start_page 8453
container_title Scientific reports
container_volume 5
creator Che, Pulin
Yang, Youfeng
Han, Xiaosi
Hu, Meng
Sellers, Jeffery C.
Londono-Joshi, Angelina I.
Cai, Guo-Qiang
Buchsbaum, Donald J.
Christein, John D.
Tang, Qinjiu
Chen, Dongquan
Li, Qianjun
Grizzle, William E.
Lu, Yin Ying
Ding, Qiang
description S100A4 expression is associated with poor clinical outcomes of patients with pancreatic cancer. The effects of loss or gain of S100A4 were examined in pancreatic cancer cell lines. S100A4 downregulation remarkably reduces cell migration and invasion, inhibits proliferation and induces apoptosis in pancreatic tumor cells. S100A4 downregulation results in significant cell growth inhibition and apoptosis in response to TGF-β1, supporting a non-canonical role of S100A4 in pancreatic cancer. The role of S100A4 in tumor progression was studied by using an orthotopic human pancreatic cancer xenograft mouse model. Tumor mass is remarkably decreased in animals injected with S100A4-deficient pancreatic tumor cells. P27 Kip1 expression and cleaved caspase-3 are increased, while cyclin E expression is decreased, in S100A4-deficient pancreatic tumors in vivo . S100A4-deficient tumors have lower expression of vascular endothelial growth factor, suggesting reduced angiogenesis. Biochemical assays revealed that S100A4 activates Src and focal adhesion kinase (FAK) signaling events and inhibition of both kinases is required to maximally block the tumorigenic potential of pancreatic cancer cells. These findings support that S100A4 plays an important role in pancreatic cancer progression in vivo and S100A4 promotes tumorigenic phenotypes of pancreatic cancer cells through the Src-FAK mediated dual signaling pathway.
doi_str_mv 10.1038/srep08453
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4326725</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1898108492</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-f995634f7a766722afe6c8b66068122d37c5457d8dee0f8b83185fc945b50faa3</originalsourceid><addsrcrecordid>eNplkU1v1DAQhi0EotXSA38AWeICSEv9HeeCVFXlQ6rUQ8vZmjhO4pK1g52U7r_H7ZbVAr7MSO_jd0bzIvSako-UcH2ak5uIFpI_Q8eMCLlmnLHnB_0ROsn5lpQnWS1o_RIdMamqSlN1jO6vKSFnAk8pbuLsMp4g2ORg9hbb0rr0IPXJ5exjwPOQ4tIPGHC7wIiz7wOMPvTl2zz8gi3euNbD7FrcbPF1shhCi7toCwvt4B49fvgA2b1CLzoYszt5qiv0_fPFzfnX9eXVl2_nZ5drK7ie111dS8VFV0GlVMUYdE5Z3ShFlKaMtbyyUsiq1a1zpNON5lTLztZCNpJ0AHyFPu18p6Upy1kX5gSjmZLfQNqaCN78rQQ_mD7eGcFZGSiLwbsngxR_Li7PZuOzdeMIwcUlG6qkKqeuGS_o23_Q27ikcqFC6VrTElPBVuj9jrIp5pJet1-GEvMQqdlHWtg3h9vvyT8BFuDDDshFCr1LByP_c_sNgcKrxQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1898108492</pqid></control><display><type>article</type><title>S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Springer Nature OA Free Journals</source><source>Nature Free</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Che, Pulin ; Yang, Youfeng ; Han, Xiaosi ; Hu, Meng ; Sellers, Jeffery C. ; Londono-Joshi, Angelina I. ; Cai, Guo-Qiang ; Buchsbaum, Donald J. ; Christein, John D. ; Tang, Qinjiu ; Chen, Dongquan ; Li, Qianjun ; Grizzle, William E. ; Lu, Yin Ying ; Ding, Qiang</creator><creatorcontrib>Che, Pulin ; Yang, Youfeng ; Han, Xiaosi ; Hu, Meng ; Sellers, Jeffery C. ; Londono-Joshi, Angelina I. ; Cai, Guo-Qiang ; Buchsbaum, Donald J. ; Christein, John D. ; Tang, Qinjiu ; Chen, Dongquan ; Li, Qianjun ; Grizzle, William E. ; Lu, Yin Ying ; Ding, Qiang</creatorcontrib><description>S100A4 expression is associated with poor clinical outcomes of patients with pancreatic cancer. The effects of loss or gain of S100A4 were examined in pancreatic cancer cell lines. S100A4 downregulation remarkably reduces cell migration and invasion, inhibits proliferation and induces apoptosis in pancreatic tumor cells. S100A4 downregulation results in significant cell growth inhibition and apoptosis in response to TGF-β1, supporting a non-canonical role of S100A4 in pancreatic cancer. The role of S100A4 in tumor progression was studied by using an orthotopic human pancreatic cancer xenograft mouse model. Tumor mass is remarkably decreased in animals injected with S100A4-deficient pancreatic tumor cells. P27 Kip1 expression and cleaved caspase-3 are increased, while cyclin E expression is decreased, in S100A4-deficient pancreatic tumors in vivo . S100A4-deficient tumors have lower expression of vascular endothelial growth factor, suggesting reduced angiogenesis. Biochemical assays revealed that S100A4 activates Src and focal adhesion kinase (FAK) signaling events and inhibition of both kinases is required to maximally block the tumorigenic potential of pancreatic cancer cells. These findings support that S100A4 plays an important role in pancreatic cancer progression in vivo and S100A4 promotes tumorigenic phenotypes of pancreatic cancer cells through the Src-FAK mediated dual signaling pathway.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/srep08453</identifier><identifier>PMID: 25677816</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>13/89 ; 631/67/1504/1713 ; 631/80/86/2366 ; 64/60 ; 96/63 ; Adhesion ; Angiogenesis ; Animals ; Apoptosis ; Caspase ; Caspase 3 - metabolism ; Caspase-3 ; Cell adhesion &amp; migration ; Cell Line, Tumor ; Cell migration ; Cell Movement - drug effects ; Cell proliferation ; Cell Proliferation - drug effects ; Cyclin E ; Cyclin E - metabolism ; Cyclin-dependent kinase inhibitor p27 ; Cyclin-Dependent Kinase Inhibitor p27 - metabolism ; Down-Regulation ; Female ; Focal adhesion kinase ; Focal Adhesion Protein-Tyrosine Kinases - metabolism ; Humanities and Social Sciences ; Humans ; Mice ; Mice, SCID ; multidisciplinary ; Pancreatic cancer ; Pancreatic Neoplasms - metabolism ; Pancreatic Neoplasms - pathology ; S100 Calcium-Binding Protein A4 ; S100 Proteins - antagonists &amp; inhibitors ; S100 Proteins - genetics ; S100 Proteins - metabolism ; S100A4 protein ; Science ; Signal Transduction ; Src protein ; src-Family Kinases - metabolism ; Transforming Growth Factor beta1 - pharmacology ; Transforming growth factor-b1 ; Transplantation, Heterologous ; Tumor cell lines ; Tumor cells ; Tumors ; Vascular endothelial growth factor ; Vascular Endothelial Growth Factor A - metabolism ; Xenografts</subject><ispartof>Scientific reports, 2015-02, Vol.5 (1), p.8453-8453, Article 8453</ispartof><rights>The Author(s) 2015</rights><rights>Copyright Nature Publishing Group Feb 2015</rights><rights>Copyright © 2015, Macmillan Publishers Limited. All rights reserved 2015 Macmillan Publishers Limited. All rights reserved</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-f995634f7a766722afe6c8b66068122d37c5457d8dee0f8b83185fc945b50faa3</citedby><cites>FETCH-LOGICAL-c438t-f995634f7a766722afe6c8b66068122d37c5457d8dee0f8b83185fc945b50faa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326725/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326725/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27903,27904,41099,42168,51555,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25677816$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Che, Pulin</creatorcontrib><creatorcontrib>Yang, Youfeng</creatorcontrib><creatorcontrib>Han, Xiaosi</creatorcontrib><creatorcontrib>Hu, Meng</creatorcontrib><creatorcontrib>Sellers, Jeffery C.</creatorcontrib><creatorcontrib>Londono-Joshi, Angelina I.</creatorcontrib><creatorcontrib>Cai, Guo-Qiang</creatorcontrib><creatorcontrib>Buchsbaum, Donald J.</creatorcontrib><creatorcontrib>Christein, John D.</creatorcontrib><creatorcontrib>Tang, Qinjiu</creatorcontrib><creatorcontrib>Chen, Dongquan</creatorcontrib><creatorcontrib>Li, Qianjun</creatorcontrib><creatorcontrib>Grizzle, William E.</creatorcontrib><creatorcontrib>Lu, Yin Ying</creatorcontrib><creatorcontrib>Ding, Qiang</creatorcontrib><title>S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>S100A4 expression is associated with poor clinical outcomes of patients with pancreatic cancer. The effects of loss or gain of S100A4 were examined in pancreatic cancer cell lines. S100A4 downregulation remarkably reduces cell migration and invasion, inhibits proliferation and induces apoptosis in pancreatic tumor cells. S100A4 downregulation results in significant cell growth inhibition and apoptosis in response to TGF-β1, supporting a non-canonical role of S100A4 in pancreatic cancer. The role of S100A4 in tumor progression was studied by using an orthotopic human pancreatic cancer xenograft mouse model. Tumor mass is remarkably decreased in animals injected with S100A4-deficient pancreatic tumor cells. P27 Kip1 expression and cleaved caspase-3 are increased, while cyclin E expression is decreased, in S100A4-deficient pancreatic tumors in vivo . S100A4-deficient tumors have lower expression of vascular endothelial growth factor, suggesting reduced angiogenesis. Biochemical assays revealed that S100A4 activates Src and focal adhesion kinase (FAK) signaling events and inhibition of both kinases is required to maximally block the tumorigenic potential of pancreatic cancer cells. These findings support that S100A4 plays an important role in pancreatic cancer progression in vivo and S100A4 promotes tumorigenic phenotypes of pancreatic cancer cells through the Src-FAK mediated dual signaling pathway.</description><subject>13/89</subject><subject>631/67/1504/1713</subject><subject>631/80/86/2366</subject><subject>64/60</subject><subject>96/63</subject><subject>Adhesion</subject><subject>Angiogenesis</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Caspase</subject><subject>Caspase 3 - metabolism</subject><subject>Caspase-3</subject><subject>Cell adhesion &amp; migration</subject><subject>Cell Line, Tumor</subject><subject>Cell migration</subject><subject>Cell Movement - drug effects</subject><subject>Cell proliferation</subject><subject>Cell Proliferation - drug effects</subject><subject>Cyclin E</subject><subject>Cyclin E - metabolism</subject><subject>Cyclin-dependent kinase inhibitor p27</subject><subject>Cyclin-Dependent Kinase Inhibitor p27 - metabolism</subject><subject>Down-Regulation</subject><subject>Female</subject><subject>Focal adhesion kinase</subject><subject>Focal Adhesion Protein-Tyrosine Kinases - metabolism</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Mice</subject><subject>Mice, SCID</subject><subject>multidisciplinary</subject><subject>Pancreatic cancer</subject><subject>Pancreatic Neoplasms - metabolism</subject><subject>Pancreatic Neoplasms - pathology</subject><subject>S100 Calcium-Binding Protein A4</subject><subject>S100 Proteins - antagonists &amp; inhibitors</subject><subject>S100 Proteins - genetics</subject><subject>S100 Proteins - metabolism</subject><subject>S100A4 protein</subject><subject>Science</subject><subject>Signal Transduction</subject><subject>Src protein</subject><subject>src-Family Kinases - metabolism</subject><subject>Transforming Growth Factor beta1 - pharmacology</subject><subject>Transforming growth factor-b1</subject><subject>Transplantation, Heterologous</subject><subject>Tumor cell lines</subject><subject>Tumor cells</subject><subject>Tumors</subject><subject>Vascular endothelial growth factor</subject><subject>Vascular Endothelial Growth Factor A - metabolism</subject><subject>Xenografts</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNplkU1v1DAQhi0EotXSA38AWeICSEv9HeeCVFXlQ6rUQ8vZmjhO4pK1g52U7r_H7ZbVAr7MSO_jd0bzIvSako-UcH2ak5uIFpI_Q8eMCLlmnLHnB_0ROsn5lpQnWS1o_RIdMamqSlN1jO6vKSFnAk8pbuLsMp4g2ORg9hbb0rr0IPXJ5exjwPOQ4tIPGHC7wIiz7wOMPvTl2zz8gi3euNbD7FrcbPF1shhCi7toCwvt4B49fvgA2b1CLzoYszt5qiv0_fPFzfnX9eXVl2_nZ5drK7ie111dS8VFV0GlVMUYdE5Z3ShFlKaMtbyyUsiq1a1zpNON5lTLztZCNpJ0AHyFPu18p6Upy1kX5gSjmZLfQNqaCN78rQQ_mD7eGcFZGSiLwbsngxR_Li7PZuOzdeMIwcUlG6qkKqeuGS_o23_Q27ikcqFC6VrTElPBVuj9jrIp5pJet1-GEvMQqdlHWtg3h9vvyT8BFuDDDshFCr1LByP_c_sNgcKrxQ</recordid><startdate>20150213</startdate><enddate>20150213</enddate><creator>Che, Pulin</creator><creator>Yang, Youfeng</creator><creator>Han, Xiaosi</creator><creator>Hu, Meng</creator><creator>Sellers, Jeffery C.</creator><creator>Londono-Joshi, Angelina I.</creator><creator>Cai, Guo-Qiang</creator><creator>Buchsbaum, Donald J.</creator><creator>Christein, John D.</creator><creator>Tang, Qinjiu</creator><creator>Chen, Dongquan</creator><creator>Li, Qianjun</creator><creator>Grizzle, William E.</creator><creator>Lu, Yin Ying</creator><creator>Ding, Qiang</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150213</creationdate><title>S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase</title><author>Che, Pulin ; Yang, Youfeng ; Han, Xiaosi ; Hu, Meng ; Sellers, Jeffery C. ; Londono-Joshi, Angelina I. ; Cai, Guo-Qiang ; Buchsbaum, Donald J. ; Christein, John D. ; Tang, Qinjiu ; Chen, Dongquan ; Li, Qianjun ; Grizzle, William E. ; Lu, Yin Ying ; Ding, Qiang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-f995634f7a766722afe6c8b66068122d37c5457d8dee0f8b83185fc945b50faa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>13/89</topic><topic>631/67/1504/1713</topic><topic>631/80/86/2366</topic><topic>64/60</topic><topic>96/63</topic><topic>Adhesion</topic><topic>Angiogenesis</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Caspase</topic><topic>Caspase 3 - metabolism</topic><topic>Caspase-3</topic><topic>Cell adhesion &amp; migration</topic><topic>Cell Line, Tumor</topic><topic>Cell migration</topic><topic>Cell Movement - drug effects</topic><topic>Cell proliferation</topic><topic>Cell Proliferation - drug effects</topic><topic>Cyclin E</topic><topic>Cyclin E - metabolism</topic><topic>Cyclin-dependent kinase inhibitor p27</topic><topic>Cyclin-Dependent Kinase Inhibitor p27 - metabolism</topic><topic>Down-Regulation</topic><topic>Female</topic><topic>Focal adhesion kinase</topic><topic>Focal Adhesion Protein-Tyrosine Kinases - metabolism</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Mice</topic><topic>Mice, SCID</topic><topic>multidisciplinary</topic><topic>Pancreatic cancer</topic><topic>Pancreatic Neoplasms - metabolism</topic><topic>Pancreatic Neoplasms - pathology</topic><topic>S100 Calcium-Binding Protein A4</topic><topic>S100 Proteins - antagonists &amp; inhibitors</topic><topic>S100 Proteins - genetics</topic><topic>S100 Proteins - metabolism</topic><topic>S100A4 protein</topic><topic>Science</topic><topic>Signal Transduction</topic><topic>Src protein</topic><topic>src-Family Kinases - metabolism</topic><topic>Transforming Growth Factor beta1 - pharmacology</topic><topic>Transforming growth factor-b1</topic><topic>Transplantation, Heterologous</topic><topic>Tumor cell lines</topic><topic>Tumor cells</topic><topic>Tumors</topic><topic>Vascular endothelial growth factor</topic><topic>Vascular Endothelial Growth Factor A - metabolism</topic><topic>Xenografts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Che, Pulin</creatorcontrib><creatorcontrib>Yang, Youfeng</creatorcontrib><creatorcontrib>Han, Xiaosi</creatorcontrib><creatorcontrib>Hu, Meng</creatorcontrib><creatorcontrib>Sellers, Jeffery C.</creatorcontrib><creatorcontrib>Londono-Joshi, Angelina I.</creatorcontrib><creatorcontrib>Cai, Guo-Qiang</creatorcontrib><creatorcontrib>Buchsbaum, Donald J.</creatorcontrib><creatorcontrib>Christein, John D.</creatorcontrib><creatorcontrib>Tang, Qinjiu</creatorcontrib><creatorcontrib>Chen, Dongquan</creatorcontrib><creatorcontrib>Li, Qianjun</creatorcontrib><creatorcontrib>Grizzle, William E.</creatorcontrib><creatorcontrib>Lu, Yin Ying</creatorcontrib><creatorcontrib>Ding, Qiang</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Che, Pulin</au><au>Yang, Youfeng</au><au>Han, Xiaosi</au><au>Hu, Meng</au><au>Sellers, Jeffery C.</au><au>Londono-Joshi, Angelina I.</au><au>Cai, Guo-Qiang</au><au>Buchsbaum, Donald J.</au><au>Christein, John D.</au><au>Tang, Qinjiu</au><au>Chen, Dongquan</au><au>Li, Qianjun</au><au>Grizzle, William E.</au><au>Lu, Yin Ying</au><au>Ding, Qiang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2015-02-13</date><risdate>2015</risdate><volume>5</volume><issue>1</issue><spage>8453</spage><epage>8453</epage><pages>8453-8453</pages><artnum>8453</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>S100A4 expression is associated with poor clinical outcomes of patients with pancreatic cancer. The effects of loss or gain of S100A4 were examined in pancreatic cancer cell lines. S100A4 downregulation remarkably reduces cell migration and invasion, inhibits proliferation and induces apoptosis in pancreatic tumor cells. S100A4 downregulation results in significant cell growth inhibition and apoptosis in response to TGF-β1, supporting a non-canonical role of S100A4 in pancreatic cancer. The role of S100A4 in tumor progression was studied by using an orthotopic human pancreatic cancer xenograft mouse model. Tumor mass is remarkably decreased in animals injected with S100A4-deficient pancreatic tumor cells. P27 Kip1 expression and cleaved caspase-3 are increased, while cyclin E expression is decreased, in S100A4-deficient pancreatic tumors in vivo . S100A4-deficient tumors have lower expression of vascular endothelial growth factor, suggesting reduced angiogenesis. Biochemical assays revealed that S100A4 activates Src and focal adhesion kinase (FAK) signaling events and inhibition of both kinases is required to maximally block the tumorigenic potential of pancreatic cancer cells. These findings support that S100A4 plays an important role in pancreatic cancer progression in vivo and S100A4 promotes tumorigenic phenotypes of pancreatic cancer cells through the Src-FAK mediated dual signaling pathway.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>25677816</pmid><doi>10.1038/srep08453</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2045-2322
ispartof Scientific reports, 2015-02, Vol.5 (1), p.8453-8453, Article 8453
issn 2045-2322
2045-2322
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4326725
source MEDLINE; DOAJ Directory of Open Access Journals; Springer Nature OA Free Journals; Nature Free; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects 13/89
631/67/1504/1713
631/80/86/2366
64/60
96/63
Adhesion
Angiogenesis
Animals
Apoptosis
Caspase
Caspase 3 - metabolism
Caspase-3
Cell adhesion & migration
Cell Line, Tumor
Cell migration
Cell Movement - drug effects
Cell proliferation
Cell Proliferation - drug effects
Cyclin E
Cyclin E - metabolism
Cyclin-dependent kinase inhibitor p27
Cyclin-Dependent Kinase Inhibitor p27 - metabolism
Down-Regulation
Female
Focal adhesion kinase
Focal Adhesion Protein-Tyrosine Kinases - metabolism
Humanities and Social Sciences
Humans
Mice
Mice, SCID
multidisciplinary
Pancreatic cancer
Pancreatic Neoplasms - metabolism
Pancreatic Neoplasms - pathology
S100 Calcium-Binding Protein A4
S100 Proteins - antagonists & inhibitors
S100 Proteins - genetics
S100 Proteins - metabolism
S100A4 protein
Science
Signal Transduction
Src protein
src-Family Kinases - metabolism
Transforming Growth Factor beta1 - pharmacology
Transforming growth factor-b1
Transplantation, Heterologous
Tumor cell lines
Tumor cells
Tumors
Vascular endothelial growth factor
Vascular Endothelial Growth Factor A - metabolism
Xenografts
title S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T13%3A58%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=S100A4%20promotes%20pancreatic%20cancer%20progression%20through%20a%20dual%20signaling%20pathway%20mediated%20by%20Src%20and%20focal%20adhesion%20kinase&rft.jtitle=Scientific%20reports&rft.au=Che,%20Pulin&rft.date=2015-02-13&rft.volume=5&rft.issue=1&rft.spage=8453&rft.epage=8453&rft.pages=8453-8453&rft.artnum=8453&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/srep08453&rft_dat=%3Cproquest_pubme%3E1898108492%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1898108492&rft_id=info:pmid/25677816&rfr_iscdi=true